Nature`s Sunshine Products (NATR) has a profit margin of 4.98%, below the Healthcare sector average of 13.89%.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
Nature`s Sunshine Products (NATR) currently reports a profit margin of 4.98% as of June 2026. That compares with 3.06% in the prior-year period — up 62.6% year over year. That is below the Healthcare sector average of 13.89%. Use the charts on this page to explore Nature`s Sunshine Products's profit margin history and peer comparisons.
Nature`s Sunshine Products's profit margin increased from 3.06% to 4.98% — a 62.6% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Nature`s Sunshine Products's profit margin of 4.98% is lower than the Healthcare sector average of 13.89%. That is roughly 64.2% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' profit margin, but Nature`s Sunshine Products's current 4.98% should be judged against Healthcare norms (sector average: 13.89%) and against NATR's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current profit margin of 4.98%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.89%. From there, open related valuation or income-statement pages for Nature`s Sunshine Products, and consider following NATR for alerts when major investors trade the stock.